There were minor changes in number of overall intrahepatic leukocytes and expression of CXCR3 in myeloid population in FHL and CD8 T cells in MAS but this therapeutic intervention did not ameliorate liver injury. This evidence concerns the gene CD8A and macrophage activation syndrome.